Pharmafile Logo
Pharmafocus logo
Advanced Search

Accession Therapeutics

Showing 1 posts of 1 posts found.

Accession Therapeutics doses first patient in new cancer immunotherapy trial

November 26, 2025
Research and Development Accession Therapeutics, Oncology

Biopharmaceutical company Accession Therapeutics has announced the dosing of the first patient in the phase 1 clinical trial of TROCEPT-01 …

News
Press release
The Gateway to Local Adoption Series

Latest content

START and Rome cancer institute partner to expand early-phase trial access in Italy

November 10, 2026

AbbVie expands Oxford R&D facility with new £120m UK research commitment

November 9, 2026

MedPharm appoints Jason Mieding as chief operating officer

November 8, 2026

UKRI backs five hubs developing AI tools for earlier disease detection

November 8, 2026

Coriolis Pharma appoints Teun van der Heide as CEO

November 7, 2026